Dr. Aref Agheli, MD

Dr. Agheli practices at Hematology-Oncology Associates of CNY in East Syracuse, New York.

Dr. Agheli's NPI, 1710204573, was assigned on May 3, 2010. Dr. Agheli holds New York license 257893.

Dr. Agheli's primary practice is Hematology-Oncology Associates of CNY, at 5008 Brittonfield Pkwy, East Syracuse, NY 13057 in Onondaga County. The practice phone is (315) 472-7504.

Dr. Agheli's primary practice is Hematology-Oncology Associates of CNY in East Syracuse, New York. Dr. Agheli is also affiliated with University of Vermont Medical Center. The medical group on file is Hematology-Oncology Associates of CNY. Dmand AI also links Dr. Agheli to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agheli practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Agheli's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Agheli is licensed in New York.

CMS data shows 94,375 Medicare services from Dr. Agheli across 89 procedure codes in 2024, for 1,033 Medicare patients. Medicare paid $738,697 for them.

CMS counts 1,033 Medicare patients who saw Dr. Agheli in 2024. The largest group is 75 to 84, with 404 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agheli's median patient age at 72, with 53% women.

In 2024, Dr. Agheli wrote 324 Medicare Part D claims for 106 patients. 65% of them were for generic drugs. CMS names the drug for 148 of them, across 8 drugs with 11 or more claims each, at $131,025 in total drug cost. In 2023, CMS named 69 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Agheli for performance year 2024, reported as part of a group. Dr. Agheli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Agheli, published from 2010 to 2012. Dr. Agheli's most frequent co-authors are Gary Shawn Becker, DO, Marvin Stewart Becker, MD and Frederick Anthony Gulmi, MD.

CMS Open Payments shows 19 general payments to Dr. Agheli from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 72% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $119.